Alcohol septal ablation in obstructive acromegalic hypertrophic cardiomyopathy - a first case report
详细信息 查看全文
- 作者：André ; Viveiros Monteiro ; andreviveirosmonteiro@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Antó ; nio Fiarresga ; Duarte Cacela ; Lí ; dia de Sousa ; Ruben Ramos ; Ana Galrinho ; Luí ; sa Branco ; Rui Cruz Ferreira
- 关键词：Hypertrophic cardiomyopathy ; Acromegaly ; Alcohol septal ablation
- 刊名：Revista Portuguesa de Cardiologia
- 出版年：2016
- 出版时间：September 2016
- 年：2016
- 卷：35
- 期：9
- 页码：499.e1-499.e4
- 全文大小：799 K
文摘
Acromegaly is a rare disease, mostly caused by a growth hormone (GH)-secreting benign pituitary tumor, with an increased production of GH and insulin-like growth factor 1 (IGF-1). Cardiovascular complications are common and are associated with cardiomyocyte apoptosis and concentric cardiac hypertrophy. Suppression of GH and IGF-1 appears to improve cardiac function only in the short term, with little or no decrease in left ventricular mass or improvement in cardiac function after prolonged treatment. Alcohol septal ablation (ASA) has emerged as a minimally invasive alternative to septal myectomy, with significant improvement in symptoms, gradients and left ventricular remodeling. In this report, we describe the case of a 73-year-old woman with acromegaly due to a pituitary adenoma diagnosed and treated surgically at the age of 38 but with recurrence and reoperation at the age of 50. She was referred to our cardiology department due to a three-month history of progressively worsening exercise-induced dyspnea and orthopnea under optimal medical therapy. Echocardiography and magnetic resonance imaging revealed severe basal hypertrophy of the interventricular septum (19 mm), dynamic left ventricular outflow tract obstruction with a gradient of 70 mmHg at rest and 120 mmHg with Valsalva maneuver, and systolic anterior movement (SAM). Genetic testing excluded the most frequent forms of familial hypertrophic cardiomyopathy. ASA was performed with injection of 2 cc of alcohol in the first septal branch of the left coronary artery, without complications. At one-year reassessment, significant clinical and echocardiographic improvement was noted, with disappearance of SAM. To our knowledge, there have been no previously reported cases of ASA in hypertrophic cardiomyopathy due to acromegaly. We report a case of successful ASA in acromegalic cardiomyopathy.